ASTH vs CNC
ASTH: Astrana Health is a physician-centric, technology-enabled platform that manages care and operations for value-based healthcare providers serving Medicare and Medicaid patients. CNC: A leading provider of government-sponsored healthcare programs, focusing on Medicaid, Medicare, and the Health Insurance Marketplace.
Side-by-side fundamentals
| Metric | ASTH | CNC | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $38.58 | $70.81 | |
| Market cap | $2.2B | $35.0B | |
| P/E as of 2026-10-20 | 47.05 | n/a | |
| Net margin FY2025, SEC XBRL | +0.7% | -3.4% | ASTH higher |
| Gross margin FY2025, SEC XBRL | n/a | +7.3% | |
| Operating margin FY2025, SEC XBRL | +2.5% | -3.9% | ASTH higher |
| ROE FY2025, SEC XBRL | +2.8% | -33.3% | ASTH higher |
| ROA FY2025, SEC XBRL | +1.0% | -8.7% | ASTH higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 1.13 | 0.71 | CNC lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +56.4% | +19.4% | ASTH higher |
| Revenue CAGR (3y) SEC XBRL | +40.6% | +10.5% | ASTH higher |
| Dividend streak (yrs) SEC XBRL | n/a | 0 | |
| Beta as of 2026-09-03 | 0.64 | 0.17 | |
| 1-year return as of 2026-10-20 close | +16.9% | +98.8% | CNC higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.